Key result
CHA2DS2-VASc score predicts ~35% higher in-hospital stroke risk after TAVI despite poor overall accuracy.
Why the study?
Stroke incidence after transcatheter aortic valve implantation remains a concern, and the predictive ability of CHADS2 and CHA2DS2-VASc scores for perioperative stroke after TAVI is unclear.
Do CHADS2 and CHA2DS2-VASc scores predict 30-day stroke in patients undergoing TAVI?
Observational (n=1,904)
Yes
Do CHADS2 and CHA2DS2-VASc scores predict 30-day stroke in patients undergoing TAVI?
While the CHA2DS2-VASc score is an independent predictor of in-hospital stroke after TAVI, its poor accuracy limits its clinical utility, highlighting the need for dedicated risk scores.
Answers are grounded in this paper and cite their sources.
Should not yet guide TAVI stroke risk assessment; leaves open need for dedicated scores.
Stroke incidence after transcatheter aortic valve implantation (TAVI) still represents a concern. This multicentre study aimed at investigating the hypothesis that CHADS2 and CHA2DS2-VASc scores may be used to predict perioperative stroke after TAVI. The Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) is a multicentre, prospective registry of patients undergoing balloon-expandable TAVI using Edwards Sapien and Sapien XT prosthesis between 2007 and 2012. The primary end-point of this study was the 30-day stroke rate. Secondary safety end-points were all the major adverse events based on Valve Academic Research Consortium (VARC-2) criteria. One thousand nine hundred and four patients were enrolled in the registry. Mean age was 81.6 ± 6.2 years and 1147 (60.2%) patients were female; mean CHADS2 and CHA2DS2-VASc scores were 2.2 ± 0.8 and 4.4 ± 1.1, respectively. Fifty-four (2.8%) patients had a stroke within 30 days. At multivariable logistic regression analysis, CHA2DS2-VASc (OR: 1.35, 95% CI: 1.03–1.78; P = 0.031) and previous cardiac surgery (OR: 1.96, 95% CI: 1.06–3.6; P = 0.033) but not CHADS2 (OR: 1.05, 95% CI: 0.76–1.44; P = 0.77) were found to be independent predictors of in-hospital stroke. A CHA2DS2-VASc score ≥5 was strongly related to the occurrence of in-hospital stroke (OR: 2.51, 95% CI: 1.38–4.57; P= 0.001). However, CHA2DS2-VASc score showed only poor accuracy for in-hospital stroke with a trend for better accuracy when compared with CHADS2 score (area under the curve: 0.61, 95% CI: 0.59–0.63 vs 0.51; 95% CI: 0.49–0.54, respectively, P = 0.092). In TAVI patients, CHA2DS2-VASc provided a strong correlation for in-hospital stroke but with low accuracy. Dedicated scores to properly tailor procedures and preventive strategies are needed.
No takes yet. Share an insight, caveat, or question.
D’Ascenzo et al. (2016) conducted an observational in Severe symptomatic aortic stenosis (n=1,904). CHA2DS2-VASc score was evaluated on 30-day in-hospital stroke rate (OR 1.35, 95% CI 1.03-1.78, p=0.031). The CHA2DS2-VASc score was an independent predictor of in-hospital stroke after transcatheter aortic valve implantation, although its overall predictive accuracy was poor.
Synapse has enriched 10 related papers. Consider them for comparative context: